✓ audited

Business review

In the Chemicals segment, sales to third parties grew by €866 million in 2012 to €13,824 million, despite lower volumes and prices. In addition to positive currency effects, portfolio effects were primarily responsible for this sales growth (volumes –3%, prices –2%, portfolio 8%, currencies 4%). Income from operations declined by €724 million to €1,718 million due to lower margins as well as to scheduled and unscheduled plant shutdowns.

We strive to increase sales in 2013. With margins stable overall, we anticipate earnings above the level of 2012.

Sales – Chemicals (million €)
Chemicals – Sales (bar chart)Enlarge image
Sales by division
Chemicals – Sales by division (pie chart)Enlarge image
Factors influencing sales – Chemicals
Chemicals – Factors influencing sales (bar chart)Enlarge image
Income from operations – Chemicals (million €)
Chemicals – Income from operations (bar chart)Enlarge image
  Download (xls, 19 kB)

Segment data Chemicals (million €)

 

 

2012

2011

Change in %

Sales to third parties

13,824

12,958

7

Thereof Inorganics

1,735

1,415

23

Petrochemicals

9,179

8,839

4

Intermediates

2,910

2,704

8

Intersegmental transfers

5,726

6,295

(9)

Sales including intersegmental transfers

19,550

19,253

2

Income from operations before depreciation and amortization (EBITDA)

2,409

3,188

(24)

EBITDA margin

%

17.4

24.6

Income from operations (EBIT) before special items

1,717

2,441

(30)

Income from operations (EBIT)

1,718

2,442

(30)

Income from operations (EBIT) after cost of capital

911

1,686

(46)

Assets

7,299

6,920

5

Research and development expenses

145

132

10

Additions to property, plant and equipment and intangible assets

920

622

48